|
|
Volumn 40, Issue 10, 2015, Pages 667-675
|
|
NME digest
a
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS;
AJS 1669;
AM 6826;
ANTICOAGULANT AGENT;
ANTIDIABETIC AGENT;
ANTIMALARIAL AGENT;
ANTINEOPLASTIC AGENT;
BLOOD CLOTTING FACTOR 11A INHIBITOR;
BMS 911172;
BROMODOMAIN INHIBITOR;
CALCIUM RELEASE ACTIVATED CALCIUM CHANNEL 1 INHIBITOR;
CCT 245737;
CM 128;
CPL 302 215;
DSR 130787;
ELIN H;
GSK 7975A;
JPC 3186;
JPC 3210;
LGLS 120A;
LIVER X RECEPTOR AGONIST;
LONG ACTING INSULIN;
ONO 7750512;
PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR;
PHOSPHOTRANSFERASE INHIBITOR;
PROTEIN INHIBITOR;
PROTEIN KINASE INHIBITOR;
PROTEIN SERINE THREONINE KINASE INHIBITOR;
UNCLASSIFIED DRUG;
UNINDEXED DRUG;
VTP 766;
ALZHEIMER DISEASE;
ANALGESIA;
ANESTHESIA;
ANTICOAGULATION;
ANTINEOPLASTIC ACTIVITY;
ARTICLE;
ASTHMA;
BLEEDING;
BRAIN CANCER;
CANCER CHEMOTHERAPY;
CANCER RESEARCH;
CENTRAL NERVOUS SYSTEM DISEASE;
DISORDERS OF MITOCHONDRIAL FUNCTIONS;
DRUG DESIGN;
DRUG DEVELOPMENT;
DRUG RESEARCH;
DUCHENNE MUSCULAR DYSTROPHY;
EPIDERMOLYSIS BULLOSA ACQUISITA;
EPILEPSY;
HUMAN;
LUNG CANCER;
NEUROPATHIC PAIN;
NON INSULIN DEPENDENT DIABETES MELLITUS;
NONHUMAN;
PANCREAS CANCER;
PANCREATITIS;
PHARMACODYNAMICS;
RISK FACTOR;
UNITED KINGDOM;
WEIGHT CONTROL;
|
|
EID: 84947286153
PISSN: 03778282
EISSN: None
Source Type: Journal
DOI: 10.1358/dof.2015.040.10.2401760 Document Type: Article |
|
Times cited : (3)
|
|
References (0)
|
